AMGEN INC is 13.9x more valuable than EXELIXIS, INC. by market capitalization ($183.41 B vs $13.22 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | EXEL | AMGN |
|---|---|---|
| Market cap | $13.22 B | $183.41 B |
| US-listed rank | #789 | #79 |
| Revenue (latest FY) | $2.32B | $36.75B |
| Net income (latest FY) | $782.60M | $7.71B |
| Net margin | 33.7% | 21.0% |
| P/E (trailing FY) | 16.9 | 23.8 |
| SEC filings | 2,488 | 1,011 |
AMGEN INC is 13.9x more valuable than EXELIXIS, INC. by market capitalization ($183.41 B vs $13.22 B).
In their latest fiscal years, EXELIXIS, INC. reported $2.32B in revenue while AMGEN INC reported $36.75B.
Full pages: EXELIXIS, INC. and AMGEN INC, or browse the full rankings.